Cargando…

Autoimmunity complicating SARS-CoV-2 infection in selective IgA-deficiency

Detalles Bibliográficos
Autores principales:	Pfeuffer, Steffen, Pawlowski, Matthias, Joos, Gunther S., Minnerup, Jens, Meuth, Sven G., Dziewas, Rainer, Wiendl, Heinz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2020
Materias:	Clinical/Scientific Notes
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7428357/ https://www.ncbi.nlm.nih.gov/pubmed/32817413 http://dx.doi.org/10.1212/NXI.0000000000000881

Ejemplares similares

A case of idiopathic multicentric Castleman disease in an alemtuzumab-treated patient with MS
por: Rolfes, Leoni, et al.
Publicado: (2019)

Skeletal muscle as potential central link between sarcopenia and immune senescence
por: Nelke, Christopher, et al.
Publicado: (2019)

Increased Intrathecal B and Plasma Cells in Patients With Anti-IgLON5 Disease: A Case Series
por: Strippel, Christine, et al.
Publicado: (2022)

Ineffective treatment of PML with pembrolizumab: Exhausted memory T-cell subsets as a clue?
por: Pawlitzki, Marc, et al.
Publicado: (2019)

IgA autoantibodies against native myelin basic protein in a patient with MS
por: Schumacher, Heike, et al.
Publicado: (2019)

Cellular Signaling and Production of Galactose-Deficient IgA1 in IgA Nephropathy, an Autoimmune Disease
por: Reily, Colin, et al.
Publicado: (2014)

A fatal case of daclizumab-induced liver failure in a patient with MS
por: Stettner, Mark, et al.
Publicado: (2019)

Subacute encephalitis with recovery in IgLON5 autoimmunity
por: Ramanan, Vijay K., et al.
Publicado: (2018)

Substance P Saliva Reduction Predicts Pharyngeal Dysphagia in Parkinson's Disease
por: Schröder, Jens Burchard, et al.
Publicado: (2019)

An Enigmatic Case of Acute Mercury Poisoning: Clinical, Immunological Findings and Platelet Function
por: Kleffner, Ilka, et al.
Publicado: (2017)

Signatures of immune reprogramming in anti-CD52 therapy of MS: markers for risk stratification and treatment response
por: Bierhansl, Laura, et al.
Publicado: (2019)

Paraneoplastic and non-paraneoplastic autoimmunity to neurons in the central nervous system
por: Melzer, Nico, et al.
Publicado: (2012)

Pretreatment anti-thyroid autoantibodies indicate increased risk for thyroid autoimmunity secondary to alemtuzumab: A prospective cohort study
por: Ruck, Tobias, et al.
Publicado: (2019)

ALAIN01—Alemtuzumab in autoimmune inflammatory neurodegeneration: mechanisms of action and neuroprotective potential
por: Ruck, Tobias, et al.
Publicado: (2016)

Alemtuzumab Improves Cognitive Processing Speed in Active Multiple Sclerosis—A Longitudinal Observational Study
por: Riepl, Ester, et al.
Publicado: (2018)

Failed, Interrupted, or Inconclusive Trials on Immunomodulatory Treatment Strategies in Multiple Sclerosis: Update 2015–2020
por: Rolfes, Leoni, et al.
Publicado: (2020)

Failed, Interrupted, or Inconclusive Trials on Neuroprotective and Neuroregenerative Treatment Strategies in Multiple Sclerosis: Update 2015–2020
por: Huntemann, Niklas, et al.
Publicado: (2021)

Aquaporin-4 IgG autoimmune syndrome and immunoreactivity associated with thyroid cancer
por: Soelberg, Kerstin, et al.
Publicado: (2016)

Primary angiitis of the central nervous system: diagnosis and treatment
por: Beuker, Carolin, et al.
Publicado: (2018)

Vitiligo after alemtuzumab treatment: Secondary autoimmunity is not all about B cells
por: Ruck, Tobias, et al.
Publicado: (2018)

Teriflunomide treatment is associated with optic nerve recovery in early multiple sclerosis
por: Pfeuffer, Steffen, et al.
Publicado: (2021)

Prednisolone and azathioprine are effective in DPPX antibody–positive autoimmune encephalitis
por: Stoeck, Katharina, et al.
Publicado: (2015)

Primary Angiitis of the CNS: A Systematic Review and Meta-analysis
por: Beuker, Carolin, et al.
Publicado: (2021)

Selective IgA Deficiency
por: Yel, Leman
Publicado: (2010)

Generating microglia from human pluripotent stem cells: novel in vitro models for the study of neurodegeneration
por: Speicher, Anna M., et al.
Publicado: (2019)

Childhood choreoathetosis secondary to hyper-IgM syndrome (CD40 ligand deficiency)
por: Coulter, Ian C., et al.
Publicado: (2020)

Therapeutic Apheresis in Acute Relapsing Multiple Sclerosis: Current Evidence and Unmet Needs—A Systematic Review
por: Rolfes, Leoni, et al.
Publicado: (2019)

Toll-like receptor 3 deficiency in autoimmune encephalitis post–herpes simplex encephalitis
por: Armangue, Thaís, et al.
Publicado: (2019)

Myelin Oligodendrocyte Glycoprotein (MOG(35-55)) Induced Experimental Autoimmune Encephalomyelitis (EAE) in C57BL/6 Mice
por: Bittner, Stefan, et al.
Publicado: (2014)

Autoantibodies Specific for Galactose-Deficient IgA1 in IgA Vasculitis With Nephritis
por: Suzuki, Hitoshi, et al.
Publicado: (2019)

IgA Antibodies and IgA Deficiency in SARS-CoV-2 Infection
por: Quinti, Isabella, et al.
Publicado: (2021)

Alemtuzumab therapy changes immunoglobulin levels in peripheral blood and CSF
por: Möhn, Nora, et al.
Publicado: (2019)

Comparison of Salivary IgA Secretion Rate Collected by the Aspiration Method and Swab Method
por: HAMURO, Koji, et al.
Publicado: (2013)

Occurrence of autoantibodies for gastrointestinal autoimmune diseases in children with common variable immune deficiency and selected IgA deficiency
por: Pituch-Noworolska, Anna, et al.
Publicado: (2013)

Effectiveness and safety of cladribine in MS: Real-world experience from two tertiary centres
por: Pfeuffer, Steffen, et al.
Publicado: (2021)

Serum galactose-deficient-IgA1 and IgG autoantibodies correlate in patients with IgA nephropathy
por: Placzek, William J., et al.
Publicado: (2018)

Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progression
por: Maixnerova, Dita, et al.
Publicado: (2019)

ELL2 Is Downregulated and Associated with Galactose-Deficient IgA1 in IgA Nephropathy
por: Liu, Youxia, et al.
Publicado: (2019)

Clinical Relevance of Serum Galactose Deficient IgA1 in Patients with IgA Nephropathy
por: Kim, Jin Sug, et al.
Publicado: (2020)

Galactose-Deficient IgA1 as a Candidate Urinary Marker of IgA Nephropathy
por: Fukao, Yusuke, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6s6kj61vu5id97o2d4otiln6la